147 related articles for article (PubMed ID: 1700316)
1. Glucose consumption and rate constants for 18F-fluorodeoxyglucose in human gliomas.
Ishikawa M; Kikuchi H; Nagata I; Yamagata S; Taki W; Yonekura Y; Nishizawa S; Iwasaki Y; Mukai T
Neurol Med Chir (Tokyo); 1990 Jun; 30(6):377-81. PubMed ID: 1700316
[TBL] [Abstract][Full Text] [Related]
2. FDG transport and phosphorylation in human gliomas measured with dynamic PET.
Herholz K; Rudolf J; Heiss WD
J Neurooncol; 1992 Feb; 12(2):159-65. PubMed ID: 1560262
[TBL] [Abstract][Full Text] [Related]
3. Independent thallium-201 accumulation and fluorine-18-fluorodeoxyglucose metabolism in glioma.
Oriuchi N; Tomiyoshi K; Inoue T; Ahmad K; Sarwar M; Tokunaga M; Suzuki H; Watanabe N; Hirano T; Horikoshi S; Shibasaki T; Tamura M; Endo K
J Nucl Med; 1996 Mar; 37(3):457-62. PubMed ID: 8772644
[TBL] [Abstract][Full Text] [Related]
4. Glucose metabolism in human malignant gliomas measured quantitatively with PET, 1-[C-11]glucose and FDG: analysis of the FDG lumped constant.
Spence AM; Muzi M; Graham MM; O'Sullivan F; Krohn KA; Link JM; Lewellen TK; Lewellen B; Freeman SD; Berger MS; Ojemann GA
J Nucl Med; 1998 Mar; 39(3):440-8. PubMed ID: 9529289
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of kinetic analysis using dynamic 18F-FDG-PET in patients with malignant primary brain tumor.
Kimura N; Yamamoto Y; Kameyama R; Hatakeyama T; Kawai N; Nishiyama Y
Nucl Med Commun; 2009 Aug; 30(8):602-9. PubMed ID: 19521265
[TBL] [Abstract][Full Text] [Related]
6. Glucose consumption in recurrent gliomas.
Ishikawa M; Kikuchi H; Miyatake S; Oda Y; Yonekura Y; Nishizawa S
Neurosurgery; 1993 Jul; 33(1):28-33. PubMed ID: 8355844
[TBL] [Abstract][Full Text] [Related]
7. Regional kinetic constants and cerebral metabolic rate for glucose in normal human volunteers determined by dynamic positron emission tomography of [18F]-2-fluoro-2-deoxy-D-glucose.
Heiss WD; Pawlik G; Herholz K; Wagner R; Göldner H; Wienhard K
J Cereb Blood Flow Metab; 1984 Jun; 4(2):212-23. PubMed ID: 6609929
[TBL] [Abstract][Full Text] [Related]
8. In vivo disturbance of the oxidative metabolism of glucose in human cerebral gliomas.
Rhodes CG; Wise RJ; Gibbs JM; Frackowiak RS; Hatazawa J; Palmer AJ; Thomas DG; Jones T
Ann Neurol; 1983 Dec; 14(6):614-26. PubMed ID: 6606389
[TBL] [Abstract][Full Text] [Related]
9. Effect of barbiturate coma on glucose utilization in normal brain versus gliomas. Positron emission tomography studies.
Blacklock JB; Oldfield EH; Di Chiro G; Tran D; Theodore W; Wright DC; Larson SM
J Neurosurg; 1987 Jul; 67(1):71-5. PubMed ID: 3496428
[TBL] [Abstract][Full Text] [Related]
10. Uncoupling of hexose transport and phosphorylation in human gliomas demonstrated by PET.
Herholz K; Ziffling P; Staffen W; Pawlik G; Wagner R; Wienhard K; Heiss WD
Eur J Cancer Clin Oncol; 1988 Jul; 24(7):1139-50. PubMed ID: 3262062
[TBL] [Abstract][Full Text] [Related]
11. [Kinetic analysis of glucose metabolism in meningiomas--comparison with malignant gliomas].
Shioya H; Mineura K; Sasajima T; Kowada M; Iida H; Ogawa T; Hatazawa J; Uemura K
No To Shinkei; 1995 Jun; 47(6):549-56. PubMed ID: 7605682
[TBL] [Abstract][Full Text] [Related]
12. Changes in glucose uptake by malignant gliomas: preliminary study of prognostic significance.
Rozental JM; Levine RL; Nickles RJ
J Neurooncol; 1991 Feb; 10(1):75-83. PubMed ID: 2022974
[TBL] [Abstract][Full Text] [Related]
13. In vivo imaging of glucose consumption and lactate concentration in human gliomas.
Herholz K; Heindel W; Luyten PR; denHollander JA; Pietrzyk U; Voges J; Kugel H; Friedmann G; Heiss WD
Ann Neurol; 1992 Mar; 31(3):319-27. PubMed ID: 1637139
[TBL] [Abstract][Full Text] [Related]
14. Glucose uptake by gliomas after treatment. A positron emission tomographic study.
Rozental JM; Levine RL; Nickles RJ; Dobkin JA
Arch Neurol; 1989 Dec; 46(12):1302-7. PubMed ID: 2556096
[TBL] [Abstract][Full Text] [Related]
15. Relation between tissue nature and (18F) fluorodeoxyglucose kinetics evaluated by dynamic positron emission tomography in human brain tumors.
Yamaguchi T; Sasaki H; Ogawa T; Mineura K; Uemura K; Kanno I; Shishido F; Murakami M; Inugami A; Higano S
Acta Radiol Suppl; 1986; 369():415-8. PubMed ID: 2980513
[TBL] [Abstract][Full Text] [Related]
16. 18-Fluorodeoxyglucose uptake and survival of patients with suspected recurrent malignant glioma.
Barker FG; Chang SM; Valk PE; Pounds TR; Prados MD
Cancer; 1997 Jan; 79(1):115-26. PubMed ID: 8988735
[TBL] [Abstract][Full Text] [Related]
17. New grading system of cerebral gliomas using positron emission tomography with F-18 fluorodeoxyglucose.
Kim CK; Alavi JB; Alavi A; Reivich M
J Neurooncol; 1991 Feb; 10(1):85-91. PubMed ID: 2022975
[TBL] [Abstract][Full Text] [Related]
18. Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography.
Di Chiro G; DeLaPaz RL; Brooks RA; Sokoloff L; Kornblith PL; Smith BH; Patronas NJ; Kufta CV; Kessler RM; Johnston GS; Manning RG; Wolf AP
Neurology; 1982 Dec; 32(12):1323-9. PubMed ID: 6983044
[TBL] [Abstract][Full Text] [Related]
19. Determination of regional rate constants from dynamic FDG-PET studies in Parkinson's disease.
Piert M; Koeppe RA; Giordani B; Minoshima S; Kuhl DE
J Nucl Med; 1996 Jul; 37(7):1115-22. PubMed ID: 8965180
[TBL] [Abstract][Full Text] [Related]
20. [Hemocirculation and metabolism in intraventricular tumors: kinetic analysis of glucose metabolism].
Shioya H; Mineura K; Kowada M; Iida H; Murakami M; Ogawa T; Hatazawa J; Uemura K
No Shinkei Geka; 1996 Mar; 24(3):211-9. PubMed ID: 8851949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]